DataMeds AI
Filed with the SEC on · accession 0001493152-26-050986
MEDS filed a S-1 (registration (ipo / new shares)) with the SEC on Nov 10, 2026. DataMeds AI filed a pre-effective amendment to its S-1 registration statement covering the resale of up to 34,462,057 shares of common stock by selling stockholders, including shares from convertible notes, preferred stock, and warrants. The stock moved -9.0% by the first close after the filing.
DataMeds AI filed a pre-effective amendment to its S-1 registration statement covering the resale of up to 34,462,057 shares of common stock by selling stockholders, including shares from convertible notes, preferred stock, and warrants. The company will not receive proceeds from the resale, though it may receive proceeds from cash warrant exercises.
Close before
$0.98
Nov 9, 2026
First close after
-8.96%
$0.90
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MEDS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MEDS?
Click hereMEDS filed a S-1 (Shelf registration). DataMeds AI filed a pre-effective amendment to its S-1 registration statement covering the resale of up to 34,462,057 shares of common stock by selling stockholders, including shares from convertible notes, preferred stock, and warrants. The company will not receive proceeds from the resale, though it may receive proceeds from cash warrant exercises.
New shares dilute existing holders and are often sold at a discount to the market price.
Registers new shares for sale, often for an IPO. Read "Use of proceeds": what the money is for. Check how many new shares there are versus shares outstanding (dilution).
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A S-1 (registration (ipo / new shares)): Registers new shares for sale, often for an IPO.
MEDS closed at $0.98 before the filing and $0.90 on Nov 10, 2026 (-8.96%).
Get alerts when MEDS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days